Inventor · disambiguated record
Bing Li
Also filed as: LI BIN · LI BING · LI BING V
73 granted patents·49 pending applications·666 citations·filing 1996–2025
99Inventor score
Files withMERCK SHARP & DOHME12DUALITY BIOLOGICS SUZHOU CO LTD11GEN ELECTRIC10GENENTECH INC8LI BING6
Top patents by PatentIndex Score
122 records- 0197US10326166B2Gel electrolytes and precursors thereofGM GLOBAL TECH OPERATIONS LLC·Filed 2016·Granted Jun 18, 2019·29 cites·13 claims
- 0296US7642255B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2008·Granted Jan 5, 2010·60 cites·6 claims
- 0395US8552002B2Compounds and compositions as protein kinase inhibitorsDING QIANG·Filed 2005·Granted Oct 8, 2013·132 cites·43 claims
- 0495US8247415B2Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonistsBERGER RICHARD·Filed 2009·Granted Aug 21, 2012·40 cites·16 claims
- 0594US11685742B2Anti-tumor compound and preparation method and use thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2022·Granted Jun 27, 2023·5 cites·8 claims
- 0694US11607459B1Anti-tumor compound and preparation method and use thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2022·Granted Mar 21, 2023·5 cites·16 claims
- 0794US8399480B2Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonistsBERGER RICHARD·Filed 2009·Granted Mar 19, 2013·36 cites·20 claims
- 0894US8076517B2Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complexHORMANN ROBERT EUGENE·Filed 2008·Granted Dec 13, 2011·21 cites·5 claims
- 0993US12091418B2Anti-tumor compound and preparation method and use thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2023·Granted Sep 17, 2024·1 cites·10 claims
- 1093US11952384B2Anti-tumor compound and preparation method and use thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2022·Granted Apr 9, 2024·1 cites·20 claims
- 1193US7951400B2Coated tablet formulation and methodBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 31, 2011·20 cites·10 claims
- 1293US6057428AVariants of vascular endothelial cell growth factorGENENTECH INC·Filed 1996·Granted May 2, 2000·90 cites·20 claims
- 1392US8354403B2Pyrrolidine derived beta 3 adrenergic receptor agonistsMERCK SHARP & DOHME·Filed 2010·Granted Jan 15, 2013·15 cites·14 claims
- 1491US9480966B2Substrates and methods for collection, stabilization and elution of biomoleculesGEN ELECTRIC·Filed 2014·Granted Nov 1, 2016·11 cites·15 claims
- 1591US9044738B2Methods and compositions for extraction and storage of nucleic acidsLI BING·Filed 2012·Granted Jun 2, 2015·11 cites·17 claims
- 1691US8653260B2Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonistsBERGER RICHARD·Filed 2012·Granted Feb 18, 2014·18 cites·11 claims
- 1790US12215163B2CD25 antibodiesIBIO INC·Filed 2021·Granted Feb 4, 2025·3 cites·24 claims
- 1890US9040679B2Methods and compositions for extraction and storage of nucleic acidsGEN ELECTRIC·Filed 2013·Granted May 26, 2015·10 cites·38 claims
- 1989US10625242B2Substrates and methods for collection, stabilization and elution of biomoleculesGEN ELECTRIC·Filed 2016·Granted Apr 21, 2020·3 cites·14 claims
- 2089US9534214B2Substrates and associated methods for elution of nucleic acidsGEN ELECTRIC·Filed 2013·Granted Jan 3, 2017·8 cites·14 claims
- 2189US9290517B2Azabenzimidazole hexahydrofuro[3,2-b]furan derivativesMERCK SHARP & DOHME·Filed 2013·Granted Mar 22, 2016·8 cites·20 claims
- 2289US2025367316A1Anti-tumor compound and preparation method and use thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2025·Application pending·0 cites
- 2387US12168667B2Anti-tumor compound and preparation method and use thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2023·Granted Dec 17, 2024·0 cites·17 claims
- 2487US9527839B2Benzimidazole tetrahydropyran derivativesMERCK SHARP & DOHME·Filed 2013·Granted Dec 27, 2016·6 cites·17 claims
- 2585US9382243B2Azabenzimidazole tetrahydropyran derivativesMERCK SHARP & DOHME·Filed 2013·Granted Jul 5, 2016·4 cites·10 claims
- 2684US12434077B2Anti-tumor compound and preparation method and use thereofDUALITY BIOLOGICS SUZHOU CO LTD·Filed 2023·Granted Oct 7, 2025·0 cites·16 claims
- 2784US7405221B2Substituted pyrimidinesMERCK & CO INC·Filed 2003·Granted Jul 29, 2008·22 cites·14 claims
- 2884US7371750B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2004·Granted May 13, 2008·21 cites·7 claims
- 2983US2024360124A1Bromodomain InhibitorsABBVIE INC·Filed 2023·Application pending·0 cites
- 3081US9540364B2Benzimidazole tetrahydrofuran derivativesMERCK SHARP & DOHME·Filed 2013·Granted Jan 10, 2017·6 cites·18 claims
- 3179US8796258B2Cyclic azabenzimidazole derivatives useful as anti-diabetic agentsANAND RAJAN·Filed 2012·Granted Aug 5, 2014·6 cites·22 claims
- 3278US9868733B2Azabenzimidazole tetrahydrofuran derivativesMERCK SHARP & DOHME·Filed 2013·Granted Jan 16, 2018·4 cites·15 claims
- 3378US9527875B2Antidiabetic tricyclic compoundsMERCK SHARP & DOHME·Filed 2013·Granted Dec 27, 2016·4 cites·13 claims
- 3478US7411955B23-layer VPN and constructing method thereofHUAWEI TECH CO LTD·Filed 2003·Granted Aug 12, 2008·32 cites·8 claims
- 3577US9834563B2Antidiabetic substituted heteroaryl compoundsMERCK SHARP & DOHME·Filed 2014·Granted Dec 5, 2017·4 cites·13 claims
- 3677US9556193B2Benzimidazole hexahydrofuro[3,2-b]furan derivativesMERCK SHARP & DOHME·Filed 2013·Granted Jan 31, 2017·4 cites·16 claims
- 3775US9598355B2Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complexINTREXON CORP·Filed 2014·Granted Mar 21, 2017·1 cites·21 claims
- 3875US8628799B2Coated tablet formulation and methodDESAI DIVYAKANT S·Filed 2011·Granted Jan 14, 2014·3 cites·11 claims
- 3975US7338957B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2004·Granted Mar 4, 2008·7 cites·8 claims
- 4075US7090834B1Vascular endothelial cell growth factor variants and uses thereofGENENTECH INC·Filed 2000·Granted Aug 15, 2006·7 cites·55 claims
- 4174US2025122301A1Cd25 antibodiesIBIO INC·Filed 2024·Application pending·0 cites
- 4273US12091345B2Method for recovering phosphorus and iron and use thereofTSINGHUA SHENZHEN INT GRADUATE SCHOOL·Filed 2024·Granted Sep 17, 2024·0 cites·13 claims
- 4373US8884060B2Process of preparing chiral diacylhydrazine ligandsHORMANN ROBERT EUGENE·Filed 2011·Granted Nov 11, 2014·1 cites·11 claims
- 4473US2020270225A1Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor ComplexINTREXON CORP·Filed 2020·Application pending·0 cites
- 4572US10202636B2Electrospun fibers for protein stabilization and storageGEN ELECTRIC·Filed 2013·Granted Feb 12, 2019·1 cites·17 claims
- 4672US9212134B2Inhibitors of viral entry into mammalian cellsBASU ARNAB·Filed 2011·Granted Dec 15, 2015·3 cites·11 claims
- 4770US10633361B2Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complexINTREXON CORP·Filed 2017·Granted Apr 28, 2020·0 cites·15 claims
- 4870US2022017511A1Bromodomain InhibitorsABBVIE INC·Filed 2021·Application pending·0 cites
- 4969US12122937B2Flexible gastight material for landfill site, and preparation method and use method thereofINST ROCK & SOIL MECH CAS·Filed 2022·Granted Oct 22, 2024·0 cites·6 claims
- 5069US11555215B2Electrospun fibers for protein stabilization and storageGlobal Life Sciences Solutions Operations UK Ltd·Filed 2019·Granted Jan 17, 2023·0 cites·23 claims
Showing the top 50 of 122 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Bing Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →